Ultrahuman Archives - Medical Design Sourcing

Ultrahuman brings in $35M to support wearable health monitoring tech

The Ring Air wearable health monitoring system. [Image courtesy of Ultrahuman]Ultrahuman announced today that it raised $35 million in an equity and debt investment round.

Blume Ventures, Steadview Capital, Nexus Venture Partners, Alpha Wave and Zomato founder Deepinder Goyal participated in the round. Ultrahuman plans to use the funds to build toward further manufacturing capacity and deeper research in the health tracking space.

Ultrahuman develops a smart ring called Ring Air, plus a continuous glucose monitor (CGM) wearable called M1 Live. It also offers a home health device called Ultrahuman Home and a preventive blood testing product called Blood Vision. The company’s platform integrates glucose, sleep, movement, blood markers and HRV for a comprehensive approach to health monitoring.

“This funding round marks a pivotal step forward in our journey to dominate the smart rings space, bringing us closer to our goal of being the market leader&…

Ultrahuman hires chief business officer as it scales expansion for glucose monitoring tech

[Image from Ultrahuman]Metabolic tracking technology developer Ultrahuman announced today that it appointed Bhuvan Srinivasan as its first chief chief business officer.

The appointment of Srinivasan to the new role follows Bangalore, India-based Ultrahuman’s $17.5 million Series B financing round completed in August.

Get the full story at our sister site, Drug Delivery Business News.

MedTech 100 roundup: On the rise again

After a slight hiccup disrupted weeks of improvement, the medtech industry again flexed its muscles over the last seven days.

MassDevice‘s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — finished last week (Aug. 20) at 119.63 points, representing a 1.5% rise from the 117.92-point tally set a week prior.

The shift marks a quick rebound from the -1.2% dip observed in the previous week and the index now sits at its highest week-ending mark ever, having actually hit an all-time best of 119.72 points on Aug. 17.

Medtech’s performance continues to reflect an overall rebound from the struggles brought on by the COVID-19 pandemic, too. The industry remains well above the marks set around the height of the pandemic, having registered a 29.6% increase from the pre-pandemic high of 92.32 (set on Feb. 19, 2020). Moreover, it remains well ahead of the mid-pandemic low of 62.13 (March 23, 2020) as well, totaling an 92.5% asc…

Ultrahuman raises $17.5M Series B for wearable glucose monitoring tech

[Image from Ultrahuman]Ultrahuman announced today that it raised $17.5 million in a Series B financing round for its wearable glucose tracking technology.

Bangalore, India-based Ultrahuman develops the Ultrahuman Cyborg, a continuous metabolism tracker designed to help people with diabetes track blood glucose in real-time and optimize their diet and exercise.

Get the full story at our sister site, Drug Delivery Business News.